Paclitaxel-eluting vs. bare metal stent implantation in saphenous vein graft lesions: Very long-term follow-up of the SOS (Stenting of Saphenous vein grafts) trial

Alan Sosa; Howard Chao; Andres Guerra; Henry Han; Georgios Christopoulos; Georgios E. Christakopoulos; Muhammad Nauman J Tarar; James A de Lemos; Owen Obel; Tayo A Addo; Michele Roesle; Donald Haagen; Bavana Venkata Rangan; Subhash Banerjee; Emmanouil S Brilakis

doi:10.1016/j.ijcard.2015.03.267

Paclitaxel-eluting vs. bare metal stent implantation in saphenous vein graft lesions: Very long-term follow-up of the SOS (Stenting of Saphenous vein grafts) trial

Alan Sosa, Howard Chao, Andres Guerra, Henry Han, Georgios Christopoulos, Georgios E. Christakopoulos, Muhammad Nauman J Tarar, James A de Lemos, Owen Obel, Tayo A Addo, Michele Roesle, Donald Haagen, Bavana Venkata Rangan, Subhash Banerjee, Emmanouil S Brilakis

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	261-263
Number of pages	3
Journal	International Journal of Cardiology
Volume	186
DOIs	https://doi.org/10.1016/j.ijcard.2015.03.267
State	Published - May 1 2015

Keywords

BMS bare-metal stent(s)
DES drug-eluting stent(s)
PES paclitaxel-eluting stent(s)
SVG saphenous vein graft

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.ijcard.2015.03.267

Cite this

Sosa, A., Chao, H., Guerra, A., Han, H., Christopoulos, G., Christakopoulos, G. E., Tarar, M. N. J., de Lemos, J. A., Obel, O., Addo, T. A., Roesle, M., Haagen, D., Rangan, B. V., Banerjee, S., & Brilakis, E. S. (2015). Paclitaxel-eluting vs. bare metal stent implantation in saphenous vein graft lesions: Very long-term follow-up of the SOS (Stenting of Saphenous vein grafts) trial. International Journal of Cardiology, 186, 261-263. https://doi.org/10.1016/j.ijcard.2015.03.267

Sosa, A, Chao, H, Guerra, A, Han, H, Christopoulos, G, Christakopoulos, GE, Tarar, MNJ, de Lemos, JA, Obel, O, Addo, TA, Roesle, M, Haagen, D, Rangan, BV, Banerjee, S & Brilakis, ES 2015, 'Paclitaxel-eluting vs. bare metal stent implantation in saphenous vein graft lesions: Very long-term follow-up of the SOS (Stenting of Saphenous vein grafts) trial', International Journal of Cardiology, vol. 186, pp. 261-263. https://doi.org/10.1016/j.ijcard.2015.03.267

@article{57d9ae00ac2746198409d1e34e39ed47,

title = "Paclitaxel-eluting vs. bare metal stent implantation in saphenous vein graft lesions: Very long-term follow-up of the SOS (Stenting of Saphenous vein grafts) trial",

keywords = "BMS bare-metal stent(s), DES drug-eluting stent(s), PES paclitaxel-eluting stent(s), SVG saphenous vein graft",

author = "Alan Sosa and Howard Chao and Andres Guerra and Henry Han and Georgios Christopoulos and Christakopoulos, {Georgios E.} and Tarar, {Muhammad Nauman J} and {de Lemos}, {James A} and Owen Obel and Addo, {Tayo A} and Michele Roesle and Donald Haagen and Rangan, {Bavana Venkata} and Subhash Banerjee and Brilakis, {Emmanouil S}",

note = "Funding Information: Dr. Brilakis: consulting/speaker honoraria from Abbott Vascular, Asahi, Boston Scientific, Elsevier, Somahlution, St Jude Medical, and Terumo; research support from Guerbet, InfraRedx, and the Department of Veterans Affairs (PI of the Drug Eluting Stents in Saphenous Vein Graft Angioplasty – DIVA trial and Merit grant – I01-CX000787-01); spouse is an employee of Medtronic. Funding Information: The SOS trial was funded by the Department of Veterans Affairs VISN-17 Startup Award and by the Clark R. Gregg grant of the Harris Methodist Foundation to Dr. Brilakis. Funding Information: Dr. Banerjee: research grants from Gilead and the Medicines Company; consultant/speaker honoraria from Covidien and Medtronic; ownership in MDCARE Global (spouse); intellectual property in HygeiaTel. ",

year = "2015",

month = may,

day = "1",

doi = "10.1016/j.ijcard.2015.03.267",

language = "English (US)",

volume = "186",

pages = "261--263",

journal = "International Journal of Cardiology",

issn = "0167-5273",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Paclitaxel-eluting vs. bare metal stent implantation in saphenous vein graft lesions

T2 - Very long-term follow-up of the SOS (Stenting of Saphenous vein grafts) trial

AU - Sosa, Alan

AU - Chao, Howard

AU - Guerra, Andres

AU - Han, Henry

AU - Christopoulos, Georgios

AU - Christakopoulos, Georgios E.

AU - Tarar, Muhammad Nauman J

AU - de Lemos, James A

AU - Obel, Owen

AU - Addo, Tayo A

AU - Roesle, Michele

AU - Haagen, Donald

AU - Rangan, Bavana Venkata

AU - Banerjee, Subhash

AU - Brilakis, Emmanouil S

N1 - Funding Information: Dr. Brilakis: consulting/speaker honoraria from Abbott Vascular, Asahi, Boston Scientific, Elsevier, Somahlution, St Jude Medical, and Terumo; research support from Guerbet, InfraRedx, and the Department of Veterans Affairs (PI of the Drug Eluting Stents in Saphenous Vein Graft Angioplasty – DIVA trial and Merit grant – I01-CX000787-01); spouse is an employee of Medtronic. Funding Information: The SOS trial was funded by the Department of Veterans Affairs VISN-17 Startup Award and by the Clark R. Gregg grant of the Harris Methodist Foundation to Dr. Brilakis. Funding Information: Dr. Banerjee: research grants from Gilead and the Medicines Company; consultant/speaker honoraria from Covidien and Medtronic; ownership in MDCARE Global (spouse); intellectual property in HygeiaTel.

PY - 2015/5/1

Y1 - 2015/5/1

KW - BMS bare-metal stent(s)

KW - DES drug-eluting stent(s)

KW - PES paclitaxel-eluting stent(s)

KW - SVG saphenous vein graft

UR - http://www.scopus.com/inward/record.url?scp=84929146964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929146964&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2015.03.267

DO - 10.1016/j.ijcard.2015.03.267

M3 - Article

C2 - 25828130

AN - SCOPUS:84929146964

SN - 0167-5273

VL - 186

SP - 261

EP - 263

JO - International Journal of Cardiology

JF - International Journal of Cardiology

ER -

Paclitaxel-eluting vs. bare metal stent implantation in saphenous vein graft lesions: Very long-term follow-up of the SOS (Stenting of Saphenous vein grafts) trial

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this